Anoro ellipta and Toothaches - a phase IV clinical study of FDA data

Summary:

Toothaches is reported as a side effect among people who take Anoro ellipta (umeclidinium bromide; vilanterol trifenatate), especially for people who are female, 60+ old, also take Paracetamol, and have Chronic obstructive pulmonary disease.

The phase IV clinical study analyzes which people have Toothaches when taking Anoro ellipta. It is created by eHealthMe based on reports of 16,408 people who have side effects when taking Anoro ellipta from the FDA, and is updated regularly.

What is Anoro ellipta?

Anoro ellipta has active ingredients of umeclidinium bromide; vilanterol trifenatate. eHealthMe is studying from 16,515 Anoro ellipta users. Check the latest studies of Anoro ellipta.

What is Toothaches?

Toothaches (tooth pain) is found to be associated with 1,324 drugs and 1,605 conditions by eHealthMe. Check the latest studies of Toothaches.

On Jul, 20, 2026

16,408 people reported to have side effects when taking Anoro ellipta.
Among them, 23 people (0.14%) have Toothaches.

Among these 23 people:

What is the gender of people who have Toothaches when taking Anoro ellipta? *

female: 77.27 %
male: 22.73 %

What is the age of people who have Toothaches when taking Anoro ellipta? *

What are other drugs people take besides Anoro ellipta? *

What are other side effects people have besides Toothaches? *

Cardiac Disorder: 9 people, 39.13%
Nausea (feeling of having an urge to vomit): 6 people, 26.09%
Headache (pain in head): 6 people, 26.09%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 6 people, 26.09%
Diarrhea: 6 people, 26.09%
Peripheral Swelling: 4 people, 17.39%
Oral Pain: 4 people, 17.39%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 4 people, 17.39%
Muscle Spasms (muscle contraction): 4 people, 17.39%
Dizziness: 4 people, 17.39%

What are the existing conditions these people have? *

Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 4 people, 17.39%
Metastatic Renal Cell Carcinoma (spreadable kidney cell tumour): 3 people, 13.04%
Cystic Fibrosis (disease of the secretary glands): 3 people, 13.04%
Broken Bone: 3 people, 13.04%
Multiple Myeloma (cancer of the plasma cells): 2 people, 8.70%
Asthma: 2 people, 8.70%
Mycobacterium Avium Complex Infection: 1 person, 4.35%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 4.35%
Dyspnea (difficult or laboured breathing): 1 person, 4.35%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 1 person, 4.35%

* Approximation only. Some reports may have incomplete information.

Do you take Anoro ellipta and have Toothaches?

- Check whether Toothaches is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Anoro ellipta:

Anoro ellipta (16,515 reports)

Toothaches treatments and more:

Toothaches (28,231 reports)

How severe was Toothaches and when was it recovered:

Toothaches in Anoro ellipta

Expand to all the drugs that have ingredients of umeclidinium bromide; vilanterol trifenatate:

Toothaches and drugs with ingredients of umeclidinium bromide; vilanterol trifenatate

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Anoro ellipta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Toothaches:

Toothaches (1,324 drugs)

Browse all the conditions that are associated with Toothaches:

Toothaches (1,605 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on umeclidinium bromide; vilanterol trifenatate (the active ingredients of Anoro ellipta) and Anoro ellipta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.